Free tool
PRHSX and HRTS: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between PRHSX and HRTS
54% of their top holdings overlap by weight, with 12 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that PRHSX holds far more positions (279 vs 45), so it is broader beyond the top names.
| Holding | % of PRHSX | % of HRTS |
|---|---|---|
| Eli Lilly & Co | 14.28% | 11.52% |
| Johnson & Johnson | 6.63% | 3.59% |
| Unitedhealth Group Inc | 5.99% | 5.24% |
| Abbvie Inc | 5.10% | 2.40% |
| Merck & Co. Inc. | 4.01% | 4.27% |
| Gilead Sciences Inc | 2.82% | 3.43% |
| Thermo Fisher Scientific Inc | 2.52% | 3.97% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.93% |
| Bristol-myers Squibb Co | 2.11% | 2.09% |
| Abbott Laboratories | 1.89% | 2.61% |
| Amgen Inc | 1.82% | 1.91% |
| Danaher Corp | 1.43% | 2.66% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized